Upadacitinib effective for treating hand eczema in AD patients
Upadacitinib was found to be effective treatment for hand eczema in patients with AD in a 16 week study.
Upadacitinib effective for treating hand eczema in AD patients
VIDEO: Study shows AD severity linked to societal economic burden in Sweden
VIDEO: Topical calcineurin inhibitor use for AD shows no cancer risk, according to study
AD prophylaxis in high-risk infants: Emollient emulsions may produce best outcomes
Study shows high percentage of ‘natural’ skin care products contain allergens
VIDEO: Study shows AD and bacterial skin infections higher in Indigenous youth
VIDEO: Prolonged corticosteroid exposure linked to adverse effects in AD patients, study shows
Spinach derivative shows promise in AD